lovastatin - PSUSA 00010051 201607 - EMA

09 March 2017
EMA/169827/2017
Human Medicines Evaluation Division
List of nationally authorised medicinal products
Active substance: lovastatin
Procedure no.: PSUSA/00010051/201607
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525
Send a question via our website www.ema.europa.eu/contact
An agency of the European Union
© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.
Product Name (in
MRP/DCP Authorisation
National Authorisation
MAH of product in the
Member State where
authorisation country)
number
Number
member state
product is authorised
Lovahexal 10 mg
DE/H/4056/001
54351.00.00
HEXAL AG
DE
DE/H/4056/001
0328607
HEXAL AG
LU
DE/H/4056/001
0328591
HEXAL AG
LU
DE/H/4056/001
0328624
HEXAL AG
LU
DE/H/4056/001
0328611
HEXAL AG
LU
DE/H/4056/001
0328641
HEXAL AG
LU
DE/H/4056/001
0328638
HEXAL AG
LU
DE/H/4056/001
0328655
HEXAL AG
LU
DE/H/4056/001
0328672
HEXAL AG
LU
DE/H/4056/001
0328669
HEXAL AG
LU
DE/H/4056/001
0328686
HEXAL AG
LU
DE/H/4056/001
0715/02/07/0021
HEXAL AG
LU
DE/H/2001/001
54354.00.00
1 A PHARMA GMBH
DE
58,751
VIFOR PHARMA ESPAÑA, S.L.
ES
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
LovaHEXAL 10 mg
Tabletten
Lovastatin - 1A Pharma
10 mg Tabletten
NERGADAN 20 mg
comprimidos
List of nationally authorised medicinal products
EMA/169827/2017
Page 2/3
Product Name (in
MRP/DCP Authorisation
National Authorisation
MAH of product in the
Member State where
authorisation country)
number
Number
member state
product is authorised
58,751
VIFOR PHARMA ESPAÑA, S.L.
ES
TAUCOR 20 mg
58757
SIGMA TAU ESPAÑA, S.A.
ES
TAUCOR 40 mg
60835
SIGMA TAU ESPAÑA, S.A.
ES
NERGADAN 20 mg
comprimidos
List of nationally authorised medicinal products
EMA/169827/2017
Page 3/3